{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:09:22Z","timestamp":1791994162882,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Health Research Institute, National Institute of Health, Islamabad Pakistan","award":["SG-21-153\/RDC\/1952"],"award-info":[{"award-number":["SG-21-153\/RDC\/1952"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00210-025-03813-9","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T04:32:27Z","timestamp":1737606747000},"page":"8761-8772","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Comparative efficacy of combined myo-inositol and D-chiro inositol versus metformin across PCOS Phenotypes: enhancing ovarian function, ovulation, and stress response in a prospective clinical trial"],"prefix":"10.1007","volume":"398","author":[{"given":"Meena","family":"Gul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Rauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Murtaza Shah","family":"Bukhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehtesham","family":"Ehtesham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Omar","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawad Ali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawaz E.","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsin","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"3813_CR1","doi-asserted-by":"publisher","first-page":"204201882093830","DOI":"10.1177\/2042018820938305","volume":"11","author":"MA Abdalla","year":"2020","unstructured":"Abdalla MA, Deshmukh H, Atkin S, Sathyapalan T (2020) A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome. Ther Adv Endocrinol Metab 11:2042018820938305","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"1","key":"3813_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/ijt.ijt_93_16","volume":"9","author":"R Aswini","year":"2017","unstructured":"Aswini R, Jayapalan S (2017) Modified Ferriman-Gallwey Score in Hirsutism and its Association with Metabolic Syndrome. Int J Trichology 9(1):7\u201313","journal-title":"Int J Trichology"},{"key":"3813_CR3","unstructured":"Awasthi S, Qurish Y. PCOS and the Role of ACTH: The Impact of the Cortisol Hormone, a Primary Stress Hormone on Mental Health. In 2023"},{"issue":"7","key":"3813_CR4","first-page":"3105","volume":"25","author":"M Azizi Kutenaei","year":"2021","unstructured":"Azizi Kutenaei M, Hosseini Teshnizi S, Ghaemmaghami P, Eini F, Roozbeh N (2021) The effects of myo-inositol vs. metformin on the ovarian function in the polycystic ovary syndrome: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci 25(7):3105\u201315","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"3813_CR5","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W et al (2009) The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91(2):456\u2013488","journal-title":"Fertil Steril"},{"key":"3813_CR6","doi-asserted-by":"publisher","first-page":"100085","DOI":"10.1016\/j.endmts.2021.100085","volume":"3","author":"J Bulsara","year":"2021","unstructured":"Bulsara J, Patel P, Soni A, Acharya S (2021) A review: Brief insight into Polycystic Ovarian syndrome. Endocr Metab Sci 3:100085","journal-title":"Endocr Metab Sci"},{"issue":"10","key":"3813_CR7","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.metabol.2008.05.008","volume":"57","author":"KI Cheang","year":"2008","unstructured":"Cheang KI, Baillargeon JP, Essah PA, Ostlund RE, Apridonize T, Islam L et al (2008) Insulin-stimulated release of d-chiro-inositol\u2013containing inositolphosphoglycan mediator correlates with insulin sensitivity in women with polycystic ovary syndrome. Metab - Clin Exp 57(10):1390\u20131397","journal-title":"Metab - Clin Exp"},{"issue":"4","key":"3813_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2307\/2136404","volume":"24","author":"S Cohen","year":"1983","unstructured":"Cohen S, Kamarck T, Mermelstein R (1983) A Global Measure of Perceived Stress. J Health Soc Behav 24(4):385\u2013396","journal-title":"J Health Soc Behav"},{"key":"3813_CR9","doi-asserted-by":"publisher","unstructured":"Cutler D. The impact of lifestyle on the reproductive, metabolic, and psychological well-being of women with polycystic ovary syndrome (PCOS). In University of British Columbia; 2019 [cited 2024 Aug 29]. Available from: https:\/\/doi.library.ubc.ca\/https:\/\/doi.org\/10.14288\/1.0378929","DOI":"10.14288\/1.0378929"},{"issue":"1","key":"3813_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1590\/S0365-05962011000100015","volume":"86","author":"HHG de Moura","year":"2011","unstructured":"de Moura HHG, Costa DLM, Bagatin E, Sodr\u00e9 CT, Manela-Azulay M (2011) Polycystic ovary syndrome: a dermatologic approach. An Bras Dermatol 86(1):111\u2013119","journal-title":"An Bras Dermatol"},{"issue":"4","key":"3813_CR11","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/jhrs.JHRS_95_18","volume":"13","author":"R Deswal","year":"2020","unstructured":"Deswal R, Narwal V, Dang A, Pundir CS (2020) The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review. J Hum Reprod Sci 13(4):261","journal-title":"J Hum Reprod Sci"},{"issue":"19","key":"3813_CR12","doi-asserted-by":"publisher","first-page":"10575","DOI":"10.3390\/ijms221910575","volume":"22","author":"S Dinicola","year":"2021","unstructured":"Dinicola S, Unfer V, Facchinetti F, Soulage CO, Greene ND, Bizzarri M et al (2021) Inositols: From Established Knowledge to Novel Approaches. Int J Mol Sci 22(19):10575","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3813_CR13","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1210\/clinem\/dgad762","volume":"109","author":"V Fitz","year":"2024","unstructured":"Fitz V, Graca S, Mahalingaiah S, Liu J, Lai L, Butt A et al (2024) Inositol for polycystic ovary syndrome: a systematic review and meta-analysis to Inform the 2023 update of the international Evidence-based PCOS guidelines. J Clin Endocrinol Metab 109(6):1630\u20131655","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"3813_CR14","first-page":"321","volume":"67","author":"C Formuso","year":"2015","unstructured":"Formuso C, Stracquadanio M, Ciotta L (2015) Myo-inositol vs. D-chiro inositol in PCOS treatment. Minerva Ginecol. 67(4):321\u20135","journal-title":"Minerva Ginecol."},{"issue":"6","key":"3813_CR15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3109\/09513590.2014.897321","volume":"30","author":"AD Genazzani","year":"2014","unstructured":"Genazzani AD, Santagni S, Rattighieri E, Chierchia E, Despini G, Marini G et al (2014) Modulatory role of D-chiro-inositol (DCI) on LH and insulin secretion in obese PCOS patients. Gynecol Endocrinol 30(6):438\u2013443","journal-title":"Gynecol Endocrinol"},{"issue":"3","key":"3813_CR16","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.3390\/ijms23031264","volume":"23","author":"R Herman","year":"2022","unstructured":"Herman R, Kravos NA, Jensterle M, Jane\u017e A, Dol\u017ean V (2022) Metformin and insulin resistance: a review of the underlying mechanisms behind changes in GLUT4-mediated glucose transport. Int J Mol Sci 23(3):1264","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3813_CR17","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4158\/EP.8.6.417","volume":"8","author":"MJ Iuorno","year":"2002","unstructured":"Iuorno MJ, Jakubowicz DJ, Baillargeon JP, Dillon P, Gunn RD, Allan G et al (2002) Effects of D-Chiro-Inositol in Lean Women with the Polycystic Ovary Syndrome. Endocr Pract 8(6):417\u2013423","journal-title":"Endocr Pract"},{"issue":"1","key":"3813_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5603\/GP.2019.0002","volume":"90","author":"M Januszewski","year":"2019","unstructured":"Januszewski M, Issat T, Jakimiuk AA, Santor-Zaczynska M, Jakimiuk AJ (2019) Metabolic and hormonal effects of a combined Myo-inositol and d-chiro-inositol therapy on patients with polycystic ovary syndrome (PCOS. Ginekol Pol 90(1):7\u201310","journal-title":"Ginekol Pol"},{"issue":"1","key":"3813_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12978-024-01758-5","volume":"21","author":"AE Juh\u00e1sz","year":"2024","unstructured":"Juh\u00e1sz AE, Stubnya MP, Teutsch B, Gede N, Hegyi P, Nyir\u00e1dy P et al (2024) Ranking the dietary interventions by their effectiveness in the management of polycystic ovary syndrome: a systematic review and network meta-analysis. Reprod Health 21(1):28","journal-title":"Reprod Health"},{"issue":"2","key":"3813_CR20","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/ijgo.13971","volume":"158","author":"G Kachhawa","year":"2022","unstructured":"Kachhawa G, Senthil Kumar KV, Kulshrestha V, Khadgawat R, Mahey R, Bhatla N (2022) Efficacy of myo-inositol and d-chiro-inositol combination on menstrual cycle regulation and improving insulin resistance in young women with polycystic ovary syndrome: A randomized open-label study. Int J Gynaecol Obstet off Organ Int Fed Gynaecol Obstet 158(2):278\u2013284","journal-title":"Int J Gynaecol Obstet off Organ Int Fed Gynaecol Obstet"},{"issue":"2","key":"3813_CR21","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1093\/ejendo\/lvad098","volume":"189","author":"J Melin","year":"2023","unstructured":"Melin J, Forslund M, Alesi S, Piltonen T, Romualdi D, Spritzer PM et al (2023) The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials. Eur J Endocrinol 189(2):S38-64","journal-title":"Eur J Endocrinol"},{"key":"3813_CR22","doi-asserted-by":"crossref","unstructured":"Monastra G, Dinicola S, Unfer V (2023) Chapter 2 - Physiological and pathophysiological roles of inositols. In: Unfer V, Dewailly D, editors. A Clinical Guide to Inositols [Internet]. Academic Press. [cited 2024 Aug 29]. p. 9\u201329. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B978032391673800008X","DOI":"10.1016\/B978-0-323-91673-8.00008-X"},{"issue":"17","key":"3813_CR23","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1056\/NEJM199904293401703","volume":"340","author":"JE Nestler","year":"1999","unstructured":"Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G (1999) Ovulatory and Metabolic Effects of d-Chiro-Inositol in the Polycystic Ovary Syndrome. N Engl J Med 340(17):1314\u20131320","journal-title":"N Engl J Med"},{"key":"3813_CR24","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1016\/S0015-0282(01)02325-1","volume":"76","author":"J Nestler","year":"2001","unstructured":"Nestler J, Gunn R, Bates S, Gregory J, Jacobson W, Rogol A (2001) D- chiro-inositol (INS1) enhances ovulatory rate in hyperandrogenemic, oligomenorrheic women with the polycystic ovary syndrome. Fertil Steril - FERT STERIL. 76:S110\u2013S111","journal-title":"Fertil Steril - FERT STERIL."},{"issue":"12","key":"3813_CR25","first-page":"5512","volume":"23","author":"M Nordio","year":"2019","unstructured":"Nordio M, Basciani S, Camajani E (2019) The 40:1 myo-inositol\/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios. Eur Rev Med Pharmacol Sci 23(12):5512\u20135521","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9588","key":"3813_CR26","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","volume":"370","author":"RJ Norman","year":"2007","unstructured":"Norman RJ, Dewailly D, Legro RS, Hickey TE (2007) Polycystic ovary syndrome. Lancet Lond Engl 370(9588):685\u2013697","journal-title":"Lancet Lond Engl"},{"issue":"12","key":"3813_CR27","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1080\/09513590701672405","volume":"23","author":"E Papaleo","year":"2007","unstructured":"Papaleo E, Unfer V, Baillargeon JP, De Santis L, Fusi F, Brigante C et al (2007) Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecol Endocrinol off J Int Soc Gynecol Endocrinol 23(12):700\u2013703","journal-title":"Gynecol Endocrinol off J Int Soc Gynecol Endocrinol"},{"issue":"3","key":"3813_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/09513590.2013.860120","volume":"30","author":"A Pizzo","year":"2014","unstructured":"Pizzo A, Lagan\u00e0 AS, Barbaro L (2014) Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol 30(3):205\u2013208","journal-title":"Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol"},{"issue":"2","key":"3813_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","volume":"132","author":"AR Polycystic","year":"2018","unstructured":"Polycystic AR, Syndrome O (2018) Obstet Gynecol 132(2):321\u2013336","journal-title":"Obstet Gynecol"},{"issue":"2","key":"3813_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000536163","volume":"89","author":"O Pustotina","year":"2024","unstructured":"Pustotina O, Myers SH, Unfer V, Rasulova I (2024) The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria. Gynecol Obstet Invest 89(2):131\u2013139","journal-title":"Gynecol Obstet Invest"},{"issue":"21","key":"3813_CR31","doi-asserted-by":"publisher","first-page":"8191","DOI":"10.3390\/ijms21218191","volume":"21","author":"X Qu","year":"2020","unstructured":"Qu X, Donnelly R (2020) Sex hormone-binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome. Int J Mol Sci 21(21):8191","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3813_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4103\/JPBS.JPBS_1_18","volume":"10","author":"S Sadeeqa","year":"2018","unstructured":"Sadeeqa S, Mustafa T, Latif S (2018) Polycystic Ovarian Syndrome-Related Depression in Adolescent Girls: A Review. J Pharm Bioallied Sci 10(2):55\u201359","journal-title":"J Pharm Bioallied Sci"},{"issue":"4","key":"3813_CR33","first-page":"337","volume":"4","author":"KI Sarkisian","year":"2023","unstructured":"Sarkisian KI, Ho L, Yang J, Mandelbaum R, Stanczyk FZ (2023) Neuroendocrine, neurotransmitter, and gut microbiota imbalance contributing to potential psychiatric disorder prevalence in polycystic ovarian syndrome. FS Rep 4(4):337\u2013342","journal-title":"FS Rep"},{"issue":"6","key":"3813_CR34","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.3390\/biomedicines11061759","volume":"11","author":"V Unfer","year":"2023","unstructured":"Unfer V, Russo M, Aragona C, Bilotta G, Montanino Oliva M, Bizzarri M (2023) Treatment with myo-inositol does not improve the clinical features in all PCOS phenotypes. Biomedicines 11(6):1759","journal-title":"Biomedicines"},{"issue":"1","key":"3813_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13048-022-01091-0","volume":"16","author":"H Zhao","year":"2023","unstructured":"Zhao H, Zhang J, Cheng X, Nie X, He B (2023) Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res 16(1):9","journal-title":"J Ovarian Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-03813-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-03813-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-03813-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T04:10:21Z","timestamp":1757131821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-03813-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["3813"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-03813-9","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures involving human participants in this study were in accordance with the ethical standards of Khyber Medical University\u2019s ethical committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards (2013). The study was approved by the institutional board of studies and informed consent was obtained from each participant\u00a0included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}